CVAC

HEALTHCARE

CureVac N.V.

—PRE

Live · NASDAQ · May 8, Close

AI Insight

What's Moving CVAC Today?

No stock-specific AI insight has been generated for CVAC yet. Check back soon — insights are generated from recent news analysis.

Fundamentals

Market Cap$1.0B

P/E Ratio7.0

EPS$0.67

Dividend Yield—

Dividend / Share—

ROE0.4%

Profit Margin1.8%

Debt / Equity—

Trading

Volume—

Avg Volume (10D)—

Shares Outstanding225.2M

CVAC News

No news articles found for CVAC yet.

Price Data

Open—

Previous Close—

Day High—

Day Low—

52 Week High$5.72

52 Week Low$3.35

Fundamentals

Market Cap$1.0B

P/E Ratio7.0

EPS$0.67

Dividend Yield—

Dividend / Share—

ROE0.4%

Profit Margin1.8%

Debt / Equity—

Trading

Volume—

Avg Volume (10D)—

Shares Outstanding225.2M

About CureVac N.V.

CureVac NV, a clinical-stage biopharmaceutical company, is focused on developing various transformative drugs based on messenger ribonucleic acid (mRNA). The company is headquartered in Tbingen, Germany.

curevac.com

Listed August 14, 2020

HEALTHCAREBIOTECHNOLOGY

Company Details

Security TypeStock

ExchangeNASDAQ

CurrencyUSD

Round Lot—

SICBIOTECHNOLOGY

CIK—

Composite FIGI—

Share Class FIGI—